Intellia Therapeutics (NTLA) P/S US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 253.6 | 0.00 | 0.00 | 19.9 | 14.4 | 28.1 | ||
| Changes by years, y/y, % | +383% | -100% | -28% | -22.8% | |||||
Intellia Therapeutics. P/S
Intellia Therapeutics. P/S, changes, %
Intellia Therapeutics (NTLA) P/S US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/S | ? | 16.1 | 18.4 | 33.1 | 14.4 | 23.0 | 28.1 | |
| Changes by years, y/y, % | -31% | -30% | +42% | |||||
| Changes by quarters, q/q, % | -21% | +14% | +80% | -56% | +60% | |||